Literature DB >> 1747017

Volunteers for biomedical research. Recruitment and screening of normal controls.

D L Shtasel1, R E Gur, P D Mozley, J Richards, M M Taleff, C Heimberg, F Gallacher, R C Gur.   

Abstract

We examined the process of accruing healthy control subjects for biomedical research on brain function. Of 1670 responders to newspaper advertising, 23.1% were uninterested when learning more about the studies, and 50.9% of those remaining were found by structured telephone screening to meet exclusionary criteria for having a history of psychiatric, neurologic, or medical disease that might affect brain function. Of 312 volunteers passing the telephone screening who came to an in-person evaluation by a physician and agreed to participate, 49.7% were found to meet exclusionary criteria, and only 157 were admitted to the study. This underscores the importance of attending to the issue of screening and assessment of "normal volunteers." Alternative strategies should be considered for enriching the pool.

Entities:  

Mesh:

Year:  1991        PMID: 1747017     DOI: 10.1001/archpsyc.1991.01810350062010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  24 in total

1.  Gender differences in regional cerebral activity during sadness.

Authors:  F Schneider; U Habel; C Kessler; J B Salloum; S Posse
Journal:  Hum Brain Mapp       Date:  2000-04       Impact factor: 5.038

2.  Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study.

Authors:  J D Ragland; R C Gur; J Raz; L Schroeder; C G Kohler; R J Smith; A Alavi; R E Gur
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 3.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

Review 4.  CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

Authors:  Eva M Peñas-Lledó; Adrián Llerena
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

5.  A description of the process of recruitment for research studies investigating the genetics of psychotic illness.

Authors:  Kimberly K Mathos; Raquel E Gur; Fran Lokar; Monica E Calkins; Vishwajit Nimgaonkar
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

6.  Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study.

Authors:  D M Censits; J D Ragland; R C Gur; R E Gur
Journal:  Schizophr Res       Date:  1997-04-11       Impact factor: 4.939

7.  Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow.

Authors:  J D Ragland; A R Coleman; R C Gur; D C Glahn; R E Gur
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

8.  Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance.

Authors:  R C Gur; B I Turetsky; M Matsui; M Yan; W Bilker; P Hughett; R E Gur
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

9.  Safety, Science, or Both? Deceptive Healthy Volunteers: Psychiatric Conditions Uncovered by Objective Methods of Screening.

Authors:  Adriana Pavletic; Maryland Pao
Journal:  Psychosomatics       Date:  2017-05-09       Impact factor: 2.386

10.  Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition.

Authors:  J Daniel Ragland; Ruben C Gur; Jeffrey N Valdez; James Loughead; Mark Elliott; Christian Kohler; Stephen Kanes; Steven J Siegel; Stephen T Moelter; Raquel E Gur
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.